Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1984 1
1988 1
1989 2
1990 1
1991 2
1994 2
1995 2
1996 1
2000 1
2001 3
2002 2
2003 4
2004 3
2005 3
2006 2
2007 1
2008 3
2009 4
2010 2
2011 2
2012 2
2013 3
2014 2
2015 6
2016 7
2017 3
2018 6
2019 7
2020 9
2021 6
2022 9
2023 6
2024 7
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Inebilizumab for Treatment of IgG4-Related Disease.
Stone JH, Khosroshahi A, Zhang W, Della Torre E, Okazaki K, Tanaka Y, Löhr JM, Schleinitz N, Dong L, Umehara H, Lanzillotta M, Wallace ZS, Ebbo M, Webster GJ, Martinez Valle F, Nayar MK, Perugino CA, Rebours V, Dong X, Wu Y, Li Q, Rampal N, Cimbora D, Culver EL; MITIGATE Trial Investigators. Stone JH, et al. N Engl J Med. 2025 Mar 27;392(12):1168-1177. doi: 10.1056/NEJMoa2409712. Epub 2024 Nov 14. N Engl J Med. 2025. PMID: 39541094 Clinical Trial.
A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis.
Nowak RJ, Benatar M, Ciafaloni E, Howard JF Jr, Leite MI, Utsugisawa K, Vissing J, Rojavin M, Li Q, Tang F, Wu Y, Rampal N, Cheng S; MINT Investigators. Nowak RJ, et al. N Engl J Med. 2025 Jun 19;392(23):2309-2320. doi: 10.1056/NEJMoa2501561. Epub 2025 Apr 8. N Engl J Med. 2025. PMID: 40202593 Clinical Trial.
COVID, complement, and the brain.
Vlaicu SI, Tatomir A, Cuevas J, Rus V, Rus H. Vlaicu SI, et al. Among authors: rus v. Front Immunol. 2023 Jul 18;14:1216457. doi: 10.3389/fimmu.2023.1216457. eCollection 2023. Front Immunol. 2023. PMID: 37533859 Free PMC article. Review.
Role of C5b-9 and RGC-32 in Cancer.
Vlaicu SI, Tatomir A, Rus V, Rus H. Vlaicu SI, et al. Among authors: rus v. Front Immunol. 2019 May 9;10:1054. doi: 10.3389/fimmu.2019.01054. eCollection 2019. Front Immunol. 2019. PMID: 31156630 Free PMC article. Review.
RGC-32 and diseases: the first 20 years.
Vlaicu SI, Tatomir A, Anselmo F, Boodhoo D, Chira R, Rus V, Rus H. Vlaicu SI, et al. Among authors: rus v. Immunol Res. 2019 Jun;67(2-3):267-279. doi: 10.1007/s12026-019-09080-0. Immunol Res. 2019. PMID: 31250246 Review.
Correction of omega-3 fatty acid deficiency and improvement in disease activity in patients with systemic lupus erythematosus treated with krill oil concentrate: a multicentre, randomised, double-blind, placebo-controlled trial.
Salmon J, Wallace DJ, Rus V, Cox A, Dykas C, Williams B, Ding Y, Hals PA, Johnsen L, Lipsky PE. Salmon J, et al. Among authors: rus v. Lupus Sci Med. 2024 Jul 14;11(2):e001201. doi: 10.1136/lupus-2024-001201. Lupus Sci Med. 2024. PMID: 39009356 Free PMC article. Clinical Trial.
Role of SIRT1 in autoimmune demyelination and neurodegeneration.
Martin A, Tegla CA, Cudrici CD, Kruszewski AM, Azimzadeh P, Boodhoo D, Mekala AP, Rus V, Rus H. Martin A, et al. Among authors: rus v. Immunol Res. 2015 Mar;61(3):187-97. doi: 10.1007/s12026-014-8557-5. Immunol Res. 2015. PMID: 25281273 Review.
113 results